Aytu Biopharma (AYTU) Change in Account Payables (2014 - 2026)

Aytu Biopharma (AYTU) has 10 years of Change in Account Payables data on file, last reported at -$1.0 million in Q1 2026.

• On a quarterly basis, Change in Account Payables fell 362.56% year-over-year to -$1.0 million in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 198.17% decrease from a year earlier, with the FY2025 full-year figure at $287000.0, up 113.82% from the prior year.
• Change in Account Payables for Q1 2026 stood at -$1.0 million, up from -$1.1 million in the prior quarter.
• Over the last five years, Change in Account Payables for AYTU reached as high as $4.6 million in Q1 2023 and fell as low as -$4.8 million in Q1 2022.
• Historically, Change in Account Payables has averaged -$245058.8 across 5 years, with a median of $134000.0 in 2024.
• Across the five-year window, Change in Account Payables jumped 232.24% in 2024 and tumbled 1174.63% in 2025, its largest moves.
• Year by year, Change in Account Payables stood at -$4.4 million in 2022, then grew by 9.42% to -$4.0 million in 2023, then soared by 54.74% to -$1.8 million in 2024, then surged by 40.3% to -$1.1 million in 2025, then gained by 3.51% to -$1.0 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$1.0 million in Q1 2026, -$1.1 million in Q4 2025, and $1.7 million in Q3 2025.